Clinical Trial Update: Comparison of the Levofloxacin Sequential Therapy and Quadruple Therapy in Second Line Treatment for HP [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing levofloxacin sequential therapy to quadruple therapy as second-line treatment for Helicobacter pylori infection has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection
• Helicobacter Pylori-associated Gastritis

Drugs mentioned

• Levofloxacin sequential therapy (levofloxacin-based sequential therapy)
• Quadruple therapy (bismuth-containing quadruple regimen)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Helicobacter | Phase 3 | Status: COMPLETED